Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications

Randall W. Moreadith, Warren Olanow, Michael D. Bentley et al.|European Polymer Journal|2016

Cited by 175